Anspach MIA 16 (16cm Minimally Invasive Attachment), Rx Only MIA16 attachments are intended fo...

FDA Device Recall #Z-0779-2014 — Class II — May 6, 2013

Recall Summary

Recall Number Z-0779-2014
Classification Class II — Moderate risk
Date Initiated May 6, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm The Anspach Effort, Inc.
Location Palm Beach Gardens, FL
Product Type Devices
Quantity 183

Product Description

Anspach MIA 16 (16cm Minimally Invasive Attachment), Rx Only MIA16 attachments are intended for use with Motor Systems for cutting and shaping bones, including the spine and cranium.

Reason for Recall

Product did not reach expected sterility assurance level

Distribution Pattern

Nationwide Distribution: FL, IL, CA. IN, MI, CA, NJ, TX, NE, NC, OR, PA, TN, DC, UT, CO, MO, KY, MD, WV, NY, and MN.

Lot / Code Information

ALL LOTS

Other Recalls from The Anspach Effort, Inc.

Recall # Classification Product Date
Z-0920-2023 Class II 7.5 cm Large Craniotome Attachment Use with XMa... Dec 7, 2022
Z-0922-2023 Class II 7.5 cm Large Rotating Craniotome Attachment. Us... Dec 7, 2022
Z-0918-2023 Class II Adult Craniotome Ref: CRANI-A-G1 Intended ... Dec 7, 2022
Z-0923-2023 Class II 6.5 cm Pediatric Craniotome Attachment. Use wit... Dec 7, 2022
Z-0924-2023 Class II Pediatric Craniotome Ref:CRANI-P-G1 Dec 7, 2022

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.